Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Sangamo BioSciences has launched a Phase I clinical trial of experimental medication SB-728-T, which aims to suppress HIV by modifying a portion of human DNA to prevent immune system cells from creating CCR5 surface receptors. The company believes a one-time exposure to the medication would create a permanent population of CD4 cells naturally resistant to HIV. --------------------- HIVers who experience treatment failure on an Aptivus-based regimen will still likely benefit later from a Prezista-based regimen, according to a study in the Journal of Acquired Immune Deficiency Syndromes. More than half of HIVers who began Prezista after a failed Aptivus regimen showed improvements in viral suppression. --------------------- A once-daily regimen of Viramune, Viread, and Epivir is associated with early virologic failure, researchers warn in the Journal of Antimicrobial Chemotherapy. More than 22% of HIVers in a study who were taking the combination experienced early nonresponse. --------------------- An ongoing Phase III clinical trial of integrase inhibitor Isentress has shown the medication is as effective in reducing viral levels in treatment-naive HIVers as the nonnucleoside analog Sustiva. Isentress is currently approved for only treatment-experienced patients. --------------------- A meta-analysis of 11 previous clinical trials published in the journal Clinical Infectious Diseases has proved what HIV caregivers had believed: HIVers adhere better to once-daily antiretroviral regimens than those taken more frequently. --------------------- Early studies of experimental anti-HIV drugs GS-9350, developed by Gilead Sciences, and SPI-452, developed by Sequoia Pharmaceuticals, have shown that the compounds may eventually rival protease inhibitor Norvir as drug-boosting agents in antiretroviral cocktails; both have chemical mechanisms similar to Norvir. --------------------- Osteoporosis medication zoledronate is effective in improving bone loss in HIV-positive adults, a study in the journal AIDS has shown. HIVers taking zoledronate for 12 months posted significant improvements in bone density, particularly in the hips. --------------------- British researchers report a case study of a 45-year-old HIV-positive man who suppressed HIV viral levels through use of only the anti-hepatitis B medication Tyzeka. The scientists believe the hepatitis treatment has anti-HIV activity and are planning additional studies of the drug. --------------------- A Phase II/IIb human clinical trial of the experimental HIV microbicide PRO2000 has shown that the gel was at least 30% effective in preventing HIV transmission from men to women during sex. --------------------- A human trial of the experimental nonnuke gel UC781, under development as a vaginal microbicide, has shown the gel is also safe and well-tolerated for use as a rectal HIV preventive product, according to University of California, Los Angeles, researchers. --------------------- Researchers at Oregon Health and Science University are developing an experimental preventive HIV vaccine to prime effector memory T cells to recognize and attack the virus when it first penetrates the body's mucosal tissues. Animal tests have shown the technique protected two thirds of vaccinated subjects.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Happy national foreskin day!
April 04 2024 1:45 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
Scarlet fever: exploring our fascination with blood
March 13 2024 1:47 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Plus: Featured Video
Latest Stories
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
Yes, HIV-positive people can safely breastfeed
June 26 2024 12:59 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Court rules to keep PrEP coverage under Obamacare
June 21 2024 5:42 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
What is Juneteenth?
June 19 2024 11:30 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Advocacy in action with AIDSWatch
May 09 2024 12:30 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
The Talk: Finding balance with HIV
May 06 2024 10:51 AM
Justice Dept plans to reschedule marijuana as a lower-risk drug
May 03 2024 2:40 PM
The Talk: Starting your journey with HIV
May 03 2024 2:00 PM
Why is a mother’s mental health so important? A doctor explains
May 01 2024 1:38 PM
Walmart to close all of its health care clinics
April 30 2024 12:30 PM
Vampire facial spa infected several women with HIV
April 29 2024 7:26 PM